ZYTOMICS Acquires Applied Spectral Imaging (ASI)

August 6, 2025

ZYTOMICS, a Berlin-based cancer diagnostics company, has acquired Applied Spectral Imaging (ASI), a leader in digital imaging solutions for pathology and cytogenetics laboratories. The acquisition will integrate ASI's imaging platforms and analysis software with ZYTOMICS' reagents, automation and analytics to create an end-to-end offering for diagnostic labs and accelerate product and technology innovation.

Buyers
ZYTOMICS
Targets
Applied Spectral Imaging (ASI)
Industry
Medical Devices
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.